2025-12-19 - Analysis Report
Here's a comprehensive analysis of Newmont Corporation (NEM) based on the provided data.

**1) Return Rate Comparison**

*   **Ticker:** NEM
*   **Company Overview:** Newmont Corporation is a leading gold producer.
*   **NEM Cumulative Return:** 86.45%
*   **VOO (S&P 500) Cumulative Return:** 99.09%
*   **Divergence:** -15.8 (Relative Divergence: 50.0)

**Analysis:** NEM has underperformed the S&P 500, with a divergence of -15.8%.  The relative divergence of 50.0 indicates that NEM's current divergence is in the middle range of its historical divergence.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha    | Beta   | Cap(B) |
|------------|--------|--------|----------|--------|--------|
| 2015-2017  | 21.0%  | 62.5%  | -8.0%    | -0.1   | 41.2   |
| 2016-2018  | 16.0%  | 68.9%  | 1.0%     | 0.0    | 38.1   |
| 2017-2019  | -7.0%  | 71.3%  | -29.0%   | 0.4    | 47.7   |
| 2018-2020  | 7.0%   | 72.6%  | -16.0%   | 0.4    | 65.8   |
| 2019-2021  | 43.0%  | 72.6%  | -4.0%    | 0.7    | 68.1   |
| 2020-2022  | -14.0% | 80.0%  | -13.0%   | 0.9    | 51.9   |
| 2021-2023  | -27.0% | 80.0%  | -29.0%   | 1.5    | 45.5   |
| 2022-2024  | -58.0% | 74.9%  | -79.0%   | 1.7    | 40.9   |
| 2023-2025  | 67.0%  | 79.1%  | 4.0%     | 1.7    | 109.1  |

**Analysis:**

*   **CAGR:** Fluctuates significantly, reflecting the cyclical nature of the gold mining industry. Recent strong performance.
*   **MDD:** Consistently high, indicating substantial drawdowns. Gold stocks can be volatile.
*   **Alpha:** Generally negative, especially recently, suggesting NEM has underperformed relative to its risk. The most recent period shows positive Alpha.
*   **Beta:** Trending upwards, particularly in recent years, indicating increased sensitivity to market movements.
*   **Cap(B):** Market cap has significantly increased in the most recent period.

**2) Recent Stock Price Fluctuations**

*   **Close:** 99.34
*   **Last-market Change:** -0.11
*   **5-day SMA:** 98.93
*   **20-day SMA:** 92.09
*   **60-day SMA:** 88.31

**Analysis:** The stock price is above its 5-day, 20-day and 60-day SMAs, indicating a short-term upward trend. The price experienced a slight decrease relative to the previous close.

**3) Indicator Analysis**

*   **MRI:** 0.7 (Medium Investment Recommended)
*   **RSI:** 70.96 (Overbought territory)
*   **PPO:** 0.77
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (11 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent Relative Divergence Change:** 5.5 (+) (Short-term increase)
*   **Expected Return (%):** -44.3

**Analysis:**

*   The RSI suggests that NEM is currently overbought, which may indicate a potential pullback in the near term.
*   The MRI suggests a "Medium Investment" recommendation.
*   The Hybrid Signal recommends buying and indicates that the investment is very safe.
*   The positive change in relative divergence suggests recent short-term upward momentum.
*   The expected return is negative.

**4) Recent News & Significant Events**

*   **Bullish Move Option:** An article discusses a potentially bullish move for NEM as the metals market thrives.
*   **Stake Sale:** Newmont is selling a stake in Fuerte Metals.
*   **Stake Reduction:** Texas Permanent School Fund Corp lowered its stake in Newmont.
*   **All-Time High:** Newmont climbed to an all-time high amid strong gold momentum.
*   **Record Free Cash Flow, Job Cuts and Insider Selling:** An article discusses conflicting signals (positive cash flow, negative job cuts and insider selling).
*   **Overvalued?** An article questions if NEM is overvalued after a surge.

**Analysis:**

Recent news paints a mixed picture. While climbing to an all-time high amid strong gold momentum is positive, there are also concerns about the stock being overvalued, stake sales, and insider selling. The conflicting signals need further investigation.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean: 1.67)
*   **Opinions:** 20
*   **Target Price (avg/high/low):** 108.89 / 133.00 / 62.00

**Analysis:** The consensus analyst rating is a "Buy" with an average target price significantly above the current price, suggesting potential upside.

**5) Recent Earnings Analysis**

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-10-23 | 1.67 | 5.52 B$   |
| 2025-07-24 | 1.86 | 5.32 B$   |
| 2025-04-24 | 1.68 | 5.01 B$   |
| 2024-10-24 | 0.8  | 4.61 B$   |
| 2025-10-23 | 0.8  | 4.61 B$   |

**Analysis:** Recent EPS and revenue have shown consistent growth, indicating positive financial performance.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue     | Profit Margin |
|--------------|-------------|---------------|
| 2025-09-30   | $5.52B      | 53.04%        |
| 2025-06-30   | $5.32B      | 50.71%        |
| 2025-03-31   | $5.01B      | 46.13%        |
| 2024-12-31   | $5.65B      | 45.51%        |
| 2024-09-30   | $4.61B      | 36.13%        |

**Capital and Profitability:**

| Quarter      | Equity      | ROE       |
|--------------|-------------|-----------|
| 2025-09-30   | $33.23B     | 5.51%     |
| 2025-06-30   | $32.11B     | 6.42%     |
| 2025-03-31   | $31.25B     | 6.05%     |
| 2024-12-31   | $29.93B     | 4.69%     |
| 2024-09-30   | $29.71B     | 3.10%     |

**Analysis:**  Revenue and Profit Margin have both increased over the recent quarters. Equity is growing, and ROE has also improved, suggesting better profitability and efficiency in utilizing equity.

**7) Comprehensive Analysis (Summary)**

Newmont (NEM) presents a mixed investment picture. While recent financial performance has been strong, with growing revenue, profit margins, and ROE, the stock has underperformed the S&P 500. There's also recent news mentioning a stake sale, insider selling and a question whether the stock is overvalued.
*   **Positive:** Recent positive earnings, rising revenue and profitability, analyst consensus "Buy" rating. The recent 67% CAGR increase.
*   **Neutral:** Medium Investment recommended.
*   **Negative:** High MDD, negative expected return, recent underperformance versus S&P 500, conflicting news headlines and the fact that the RSI indicates the stock is overbought.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.